CTLA4Ig inhibits alloantibody responses to transfusions and transplants.
Ibrahim
S
S
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jakobs
F
F
Linsley
P S
PS
Sanfilippo
F
F
Baldwin
W M
WM
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000494:pharmacology*; D001803:Blood Transfusion; D060908:CTLA-4 Antigen; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D018796:Immunoconjugates; D007074:Immunoglobulin G / Q000096:biosynthesis; D007165:Immunosuppression Therapy / Q000379:methods; D007518:Isoantibodies / Q000096:biosynthesis*; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D013997:Time Factors; D014184:Transplantation, Homologous
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; D018796:Immunoconjugates; D007074:Immunoglobulin G; D007518:Isoantibodies; D000069594:Abatacept